Healthcare
Alnylam Pharmaceuticals (ALNY)
Alnylam Pharmaceuticals stock analysis and opportunity scoring
$240.69
↑ +1.51%
Alnylam Pharmaceuticals (ALNY) at a glance
Alnylam Pharmaceuticals (ALNY) is a publicly traded company in the Healthcare - Biotechnology sector tracked by MKD Intelligence.
ALNY last traded at $205.52 as of 2026-09-01.
MKD Intelligence assigns ALNY a composite opportunity score of 65 out of 100, indicating mixed conditions across trend, momentum and volume factors.
The risk score for ALNY is 52 out of 100 (moderate), where a higher number means greater expected volatility.
Price History
High
$242.61
Low
$205.52
Period
Aug 31 - Jul 31 (22d)
Hover for details • Scroll to zoom • Drag to pan • Double-click to reset
Recent News
No recent news available.
Upcoming Events
Data as of Sep 1
This platform provides market intelligence and educational information only. It does not constitute financial advice, and no information presented should be interpreted as a recommendation to buy, sell, or hold any security. Past performance and historical patterns do not guarantee future results.